Imatinib Mesylate IP CAS NO. 220127-57-1

Imatinib Mesylate IP CAS NO. 220127-57-1 Specification

Molecular Formula
C30H35N7O4S

Molecular Weight
589.71 GSM (gm/2)

Medicine Name
Imatinib Mesylate IP

Chemical Name
Imatinib Mesylate IP

CAS No
220127-57-1

Type
Pharmaceutical Intermediates

Grade
Industrial Grade

Usage
Imatinib is used for treating chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and gastrointestinal stromal tumors (GIST) by inhibiting specific cancer-driving tyrosine kinases.

Purity(%)
99.60 %

Appearance
Slightly yellowish Powder

Physical Form
Powder

Imatinib Mesylate IP CAS NO. 220127-57-1 Trade Information

Minimum Order Quantity
1 Kilograms

Delivery Time
1 Week

About Imatinib Mesylate IP CAS NO. 220127-57-1

Imatinib, also known by synonyms such as Imatinib Mesylate, STI-571, and Gleevec, is a targeted tyrosine kinase inhibitor primarily used in the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). It works by selectively blocking the BCR-ABL fusion protein and other tyrosine kinases responsible for uncontrolled cancer cell proliferation, offering high efficacy with reduced toxicity compared to conventional chemotherapy.

Tell us about your requirement